Role of xenobiotic efflux transporters in resistance to vincristine

Rong S. Huang, Daryl J Murry, David R. Foster

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

This study characterized interactions between efflux transporters (P-glycoprotein (MDR1) and multidrug resistance associated proteins (MRPs1-3)) and vincristine (VCR), using cell lines with differential transporter expression, and studied effects of P-glycoprotein inhibition on VCR transport and toxicity. Caco2 (express MDR1, MRPs 1-3), LS174T (express MDR1, MRPs 1, 3), and A549 (express MRPs 1-3) cells were used. To study VCR transport (effective permeability, Peff), VCR (1-500 nM) was added to the donor chambers of permeable supports containing Caco2 monolayers, and receiving chamber concentrations were measured. Cytotoxicity experiments were conducted with escalating concentrations of VCR in all cell lines. To determine the contribution of MDR1, experiments were also conducted with LY335979, a specific MDR1 inhibitor. VCR Peff was 2 × 10-6 cm/s in Caco2 cells. LY335979 increased Peff in a dose dependent manner (up to 7-fold with 1 μM LY335979) in Caco2 cells. Caco2 and LS174T cell viability decreased significantly when co-incubated with both VCR and LY335979 (1 μM) (P < 0.05), however this was not observed in A549 cells. In summary, MDR1 plays an important role in VCR efflux; MDR1 inhibition increased VCR Peff in Caco2 cells, and increased VCR cytotoxicity in Caco2 and LS174T cells (both express MDR1), but not A549 cells (minimal MDR1 expression). Inhibition of MDR1 may be a viable strategy to overcome VCR resistance in tumors expressing MDR1, however the presence of other efflux transporters should also be considered, as this will influence the success of such strategies.

Original languageEnglish (US)
Pages (from-to)59-64
Number of pages6
JournalBiomedicine and Pharmacotherapy
Volume62
Issue number2
DOIs
StatePublished - Feb 1 2008

Fingerprint

Vincristine
Xenobiotics
zosuquidar trihydrochloride
P-Glycoprotein
Cell Line
Permeability
Cell Survival

Keywords

  • MDR1
  • Multidrug resistance associated proteins
  • P-glycoprotein
  • Transporters
  • Vincristine

ASJC Scopus subject areas

  • Pharmacology

Cite this

Role of xenobiotic efflux transporters in resistance to vincristine. / Huang, Rong S.; Murry, Daryl J; Foster, David R.

In: Biomedicine and Pharmacotherapy, Vol. 62, No. 2, 01.02.2008, p. 59-64.

Research output: Contribution to journalArticle

Huang, Rong S. ; Murry, Daryl J ; Foster, David R. / Role of xenobiotic efflux transporters in resistance to vincristine. In: Biomedicine and Pharmacotherapy. 2008 ; Vol. 62, No. 2. pp. 59-64.
@article{259172e523494956a28ce90a6b00f7e2,
title = "Role of xenobiotic efflux transporters in resistance to vincristine",
abstract = "This study characterized interactions between efflux transporters (P-glycoprotein (MDR1) and multidrug resistance associated proteins (MRPs1-3)) and vincristine (VCR), using cell lines with differential transporter expression, and studied effects of P-glycoprotein inhibition on VCR transport and toxicity. Caco2 (express MDR1, MRPs 1-3), LS174T (express MDR1, MRPs 1, 3), and A549 (express MRPs 1-3) cells were used. To study VCR transport (effective permeability, Peff), VCR (1-500 nM) was added to the donor chambers of permeable supports containing Caco2 monolayers, and receiving chamber concentrations were measured. Cytotoxicity experiments were conducted with escalating concentrations of VCR in all cell lines. To determine the contribution of MDR1, experiments were also conducted with LY335979, a specific MDR1 inhibitor. VCR Peff was 2 × 10-6 cm/s in Caco2 cells. LY335979 increased Peff in a dose dependent manner (up to 7-fold with 1 μM LY335979) in Caco2 cells. Caco2 and LS174T cell viability decreased significantly when co-incubated with both VCR and LY335979 (1 μM) (P < 0.05), however this was not observed in A549 cells. In summary, MDR1 plays an important role in VCR efflux; MDR1 inhibition increased VCR Peff in Caco2 cells, and increased VCR cytotoxicity in Caco2 and LS174T cells (both express MDR1), but not A549 cells (minimal MDR1 expression). Inhibition of MDR1 may be a viable strategy to overcome VCR resistance in tumors expressing MDR1, however the presence of other efflux transporters should also be considered, as this will influence the success of such strategies.",
keywords = "MDR1, Multidrug resistance associated proteins, P-glycoprotein, Transporters, Vincristine",
author = "Huang, {Rong S.} and Murry, {Daryl J} and Foster, {David R.}",
year = "2008",
month = "2",
day = "1",
doi = "10.1016/j.biopha.2007.04.011",
language = "English (US)",
volume = "62",
pages = "59--64",
journal = "Biomedicine and Pharmacotherapy",
issn = "0753-3322",
publisher = "Elsevier Masson",
number = "2",

}

TY - JOUR

T1 - Role of xenobiotic efflux transporters in resistance to vincristine

AU - Huang, Rong S.

AU - Murry, Daryl J

AU - Foster, David R.

PY - 2008/2/1

Y1 - 2008/2/1

N2 - This study characterized interactions between efflux transporters (P-glycoprotein (MDR1) and multidrug resistance associated proteins (MRPs1-3)) and vincristine (VCR), using cell lines with differential transporter expression, and studied effects of P-glycoprotein inhibition on VCR transport and toxicity. Caco2 (express MDR1, MRPs 1-3), LS174T (express MDR1, MRPs 1, 3), and A549 (express MRPs 1-3) cells were used. To study VCR transport (effective permeability, Peff), VCR (1-500 nM) was added to the donor chambers of permeable supports containing Caco2 monolayers, and receiving chamber concentrations were measured. Cytotoxicity experiments were conducted with escalating concentrations of VCR in all cell lines. To determine the contribution of MDR1, experiments were also conducted with LY335979, a specific MDR1 inhibitor. VCR Peff was 2 × 10-6 cm/s in Caco2 cells. LY335979 increased Peff in a dose dependent manner (up to 7-fold with 1 μM LY335979) in Caco2 cells. Caco2 and LS174T cell viability decreased significantly when co-incubated with both VCR and LY335979 (1 μM) (P < 0.05), however this was not observed in A549 cells. In summary, MDR1 plays an important role in VCR efflux; MDR1 inhibition increased VCR Peff in Caco2 cells, and increased VCR cytotoxicity in Caco2 and LS174T cells (both express MDR1), but not A549 cells (minimal MDR1 expression). Inhibition of MDR1 may be a viable strategy to overcome VCR resistance in tumors expressing MDR1, however the presence of other efflux transporters should also be considered, as this will influence the success of such strategies.

AB - This study characterized interactions between efflux transporters (P-glycoprotein (MDR1) and multidrug resistance associated proteins (MRPs1-3)) and vincristine (VCR), using cell lines with differential transporter expression, and studied effects of P-glycoprotein inhibition on VCR transport and toxicity. Caco2 (express MDR1, MRPs 1-3), LS174T (express MDR1, MRPs 1, 3), and A549 (express MRPs 1-3) cells were used. To study VCR transport (effective permeability, Peff), VCR (1-500 nM) was added to the donor chambers of permeable supports containing Caco2 monolayers, and receiving chamber concentrations were measured. Cytotoxicity experiments were conducted with escalating concentrations of VCR in all cell lines. To determine the contribution of MDR1, experiments were also conducted with LY335979, a specific MDR1 inhibitor. VCR Peff was 2 × 10-6 cm/s in Caco2 cells. LY335979 increased Peff in a dose dependent manner (up to 7-fold with 1 μM LY335979) in Caco2 cells. Caco2 and LS174T cell viability decreased significantly when co-incubated with both VCR and LY335979 (1 μM) (P < 0.05), however this was not observed in A549 cells. In summary, MDR1 plays an important role in VCR efflux; MDR1 inhibition increased VCR Peff in Caco2 cells, and increased VCR cytotoxicity in Caco2 and LS174T cells (both express MDR1), but not A549 cells (minimal MDR1 expression). Inhibition of MDR1 may be a viable strategy to overcome VCR resistance in tumors expressing MDR1, however the presence of other efflux transporters should also be considered, as this will influence the success of such strategies.

KW - MDR1

KW - Multidrug resistance associated proteins

KW - P-glycoprotein

KW - Transporters

KW - Vincristine

UR - http://www.scopus.com/inward/record.url?scp=38949113151&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38949113151&partnerID=8YFLogxK

U2 - 10.1016/j.biopha.2007.04.011

DO - 10.1016/j.biopha.2007.04.011

M3 - Article

VL - 62

SP - 59

EP - 64

JO - Biomedicine and Pharmacotherapy

JF - Biomedicine and Pharmacotherapy

SN - 0753-3322

IS - 2

ER -